10 Jun 2026Open access
Computational Evaluation of Novel PARP-1 Inhibitors for Breast Cancer: Docking, Molecular Dynamics, MM/GBSA, DFT and ADMET CalculationsPublisher sitePharmaceuticals, PARP inhibition in cancer therapy
Active, last published 2026
In computational drug discovery methods
Ephraim Felix
Marondedze
Scholar“Research focused on Computational Drug Discovery Methods and adjacent fields.”
University of Johannesburg
South Africa3
H-index
74
Citations
Ephraim has not officially claimed their profile. If you are Ephraim, claim it free.
Claim Your Profile
Pioneer
LOCKED
Pathfinder
LOCKED
Scholar
EARNED
Innovator
LOCKED
Inventor
LOCKED
Catalyst
LOCKED
Expert
UPGRADE
01 · About the work
What I study
phraim Felix Marondedze is a researcher working on Computational Drug Discovery Methods. A fuller summary will appear once they update their profile.
02 · Reach
Publication output and reach
Ephraim's work has been cited 74 times across 1 active year. Bars show publications per year; the line shows cumulative citation totals across publications first appearing in each year.
03 · Research focus
Topics
Computational Drug Discovery Methods×7Protein Structure and Dynamics×2Alzheimer's disease research and treatments×2Advanced biosensing and bioanalysis techniques×2Electrochemical sensors and biosensors×2
04 · Where I am
Affiliations
Affiliation on published researchUniversity of Johannesburg, South AfricaDrawn from the institution listed on this researcher’s published work.
Research themes (UN SDGs)
05 · Selected work
Recent publications
1 workExpert Academic Profiles go further
Citation trend analytics, exportable publication records, and direct enquiry routing from industry and funders.
Are you Ephraim?
Claim it to verify your details, connect with industry partners, and explore Fractional Domain Expert opportunities through MARATTO™.
African researchers are full of potential that too often goes unrecognised. Your MARATTO™ profile gives your work the commercial pathway it deserves.
Claim Your Profile
Free to claim · takes a minute to verify it’s you